Gossamer Bio, Inc. (GOSS)
0.4371
-0.02
(-4.98%)
USD |
NASDAQ |
Mar 13, 16:00
0.44
0.00 (0.00%)
After-Hours: 20:00
Gossamer Bio Total Assets (Quarterly) : 208.82M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 488.95M |
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Kyntra Bio, Inc. | 137.01M |
| Artelo Biosciences, Inc. | 2.801M |
| Axsome Therapeutics, Inc. | 689.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 291.15M |
| Shareholders Equity (Quarterly) | -82.33M |
| Debt to Equity Ratio | -2.464 |
| Current Ratio | 3.284 |
| Net Debt Paydown Yield | -0.13% |